ReviewDrug design, development and therapy2024

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Eleftherios Chatzimichail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.